Lasa Supergenerics Limited
Incorporated in 2016, Lasa Supergenerics Ltd is in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc.
What Lasa files
- Others40
- Board Meeting18
- Important15
- Updates5
- Results5
Lasa Supergenerics has appointed Mr. Janardan Savala as Executive Director and factory occupier for five years. The company also re-appointed Dr. Omkar Herlekar and appointed Mr. Shivam Sharma as secretarial auditor for a five-year term, alongside scheduling its upcoming annual general meeting.
Lasa Supergenerics has announced a board meeting on convening its 11th Annual General Meeting, alongside proposing the re-appointment of Mr. Omkar Herlekar and appointing Mr. Janardan Savala as Executive Director.
Lasa Supergenerics' Board has approved a key leadership change, appointing Mr. Janardan Savala as an Additional Executive Director and Occupier for all units. This decision requires shareholder approval.
Lasa Supergenerics Limited has informed the Exchange regarding Cessation of Mr. ganesh as Executive Director of the company w.e.f. August 25, 2026.
Lasa Supergenerics held a board meeting on August 14, 2026, where it approved the financial results for the quarter ended June 30, 2026. 1. **Financial Performance:** The company's operations remain severely impacted by a major fire in May 2025 at its primary, uninsured factory. This incident continues to halt all...